ExpressCells, Inc. — Form D
ExpressCells, Inc. of PHILADELPHIA, PA, a company, filed a Form D exempt-offering notice with the SEC on 2019-06-24. The offering totals $1.0M, of which $800K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-06-24
- Form: D
- Accession: 0001780502-19-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $800K
- Remaining: $200K
- Investors: 8
- Date of first sale: 2019-06-06
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-342555
Issuer
- Name: ExpressCells, Inc.
- CIK: 0001780502
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 3675 MARKET ST., SUITE 200, PHILADELPHIA, PA, 19104
- Phone: 484-802-7419
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Tom Anderson | Director | Chicago, IL |
| Wendy DiCicco | Director | Boston, MA |
| Matthew Handel | Director | Philadelphia, PA |
| Matthew Handel | Executive Officer | Philadelphia, PA |
| Sajad Bilgrami | Director | Philadelphia, PA |
Other filings by this issuer (2)
More